Top Suppliers:I want be here



863029-99-6

863029-99-6 structure
863029-99-6 structure
  • Name: MKI 833
  • Chemical Name: 4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile
  • CAS Number: 863029-99-6
  • Molecular Formula: C30H32ClN7OS
  • Molecular Weight: 574.13900
  • Catalog: Research Areas Cancer
  • Create Date: 2017-03-11 15:34:31
  • Modify Date: 2024-01-17 20:05:23
  • MKI 833 (Balamapimod) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity.

Name 4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile
Synonyms 4-({3-chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile
MKI-833
4-({3-chloro-4-[(1-methyl-1H-imidazole-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile
UNII-7Y0IV7N95Q
Balamapimod
Balamapimod (USAN)
MKI 833
Description MKI 833 (Balamapimod) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity.
Related Catalog
Target

MEK

References

[1]. Jose R. Conejo-Garcia, et al. Methods and compositions for treatment of metastatic and refractory cancers and tumors. US20170020964A1.

Molecular Formula C30H32ClN7OS
Molecular Weight 574.13900
Exact Mass 573.20800
PSA 110.77000
LogP 5.88618

~%

863029-99-6 structure

863029-99-6

Literature: Wyeth Patent: US2005/187247 A1, 2005 ; Location in patent: Page/Page column 23 ; US 20050187247 A1